Humanized monoclonal antibodies to treat mucormycosis

Ended Project Grant Awarded Last action

Award ID
R43AI138904
Recipient
Awarding agency
Obligated
$599,718

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$30
Amendment Humanized monoclonal antibodies to treat mucormycosis - mucormycosis, most commonly caused by rhizopus oryzae, is a life-threatening infection that occurs in… -$30
Amendment $299,778
Original award $300,000

Quick answers

Who received award R43AI138904?

R43AI138904 was awarded to Vitalex Biosciences, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 9, 2018.

How much is award R43AI138904 worth?

$599,718 has been obligated on R43AI138904.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award